SARS-CoV-2 Neutralizing Antibody Treatment in COVID-19 Patients With B-Cell Non-Hodgkin Lymphoma and Immunodeficiency
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma
Blood Adv 2021 Dec 15;[EPub Ahead of Print], JJ Malin, V Di Cristanziano, C Horn, E Pracht, J Garcia Borrega, E Heger, E Knops, R Kaiser, B Boll, C Lehmann, N Jung, P Borchmann, G Faetkenheuer, F Klein, M Hallek, J RybnikerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.